semaglutide injection patent expiry Last week's of the for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions Patent Expiry Day: Novo Nordisk

We monitor patients throughout their weight loss journey with regular lab work and nutritional counseling

In fact, BPC-157 is so effective at healing this condition that scientists are considering the possibility of making it a viable treatment for it

ESSAY CONTEST WINNERS: A Cup's Perspective Alice Baratelli (Faculty/Practitioner Category) Global Health is All About Touching Lives Christopher Dukat (LMIC Trainee Category) Why being Shirtless in The Dominican will Make me a Better Doctor Kyle Nguyen (Trainee Category) HONORABLE MENTION: Balancing Measures Caitrin Kelly Infectious Conversations Frank N Working Towards Positive Freedom Anastazia Prost Bridging Silence Alia Pederson & Lauren Contreras Moderator: Christine Ngaruiya Come support the next generation of researchers by attending the oral abstracts presentations where emerging minds present their cutting-edge work, groundbreaking ideas, and fresh perspectives

Nutrient Deficiencies Eating less sometimes means eating less well

Phase I Safety Profile: While topical and low-dose injectable formulations demonstrate high tolerance and minimal systemic toxicity, there is no formal Phase I safety data for chronic 85 mg/day intranasal delivery in humans